Clinigen Share Discussion Threads

[rampmeister] 20/1/2016 10:16

Agree update figures look reasonable but 100%+ revenue growth following acquisitions was a given although they have at least delivered on that. What the market expects to see is evidence of a return to double digit growth.Maybe we will hear further when full numbers are given in March.

RM

[vantare7] 19/1/2016 18:30

I thought the trading update was reasonable, and was surprised to see the share price drop of so much ending down 37. I know the directors sold a lot of shares in October but it seems to have been hit very hard today

[rampmeister] 11/1/2016 00:24

Odd that chart closely tracks GSK during this period ...probably a coincidence.

RM

[apad] 10/1/2016 10:47

Large director sales. Oct 15 at 685p when price was 700+ drove price down not sector malaise.
apad

[rampmeister] 10/1/2016 10:41

T/U announcement date Jan 19th with analysts invited along for presentation. Not a good time to be out of these with a good T/U likely and benefits of IDIS acquistion seriously kicking in. Hoping share price will soon be revisiting earlier highs circa 800p. Sector malaise has been holding share price back imho.

From finals last september:-

"The addition of Idis in April, the strategic alliance with Cumberland in the US and today's proposed acquisition of Link, have and will transform our international reach and capabilities, and will continue to accelerate our growth.

"With Idis, we are now the market leader in the $5+ billion unlicensed medicine supply sector and in the $2 billion clinical trial supply market. The addition of Link will substantially increase our international footprint into the Asia, Africa and Australasia region.

"Looking forward, the integration of Idis is progressing well and trading is in line with the Board's expectations at this early stage of the year. The Board remains confident about the outlook for the full year."

RM

[gucci] 30/12/2015 19:44

Great finish today

[gargleblaster] 30/12/2015 17:28

New highs - imminent imv!

[gswredland] 30/12/2015 12:48

Yep does look encouraging nurdin

[nurdin] 29/12/2015 20:43

The chart is certainly curving up.Earnings growth over the next couple of years forecast to outstrip PE ratio by some margin...I think we are at a cusp of a major move upwards,both on TA and FA.Lets see.

[gucci] 29/12/2015 17:50

Let's hope for a breakout beyond 750p

[marine boy] 09/12/2015 11:59

And still she climbs at 695p on the bid.

[marine boy] 30/11/2015 16:11

This has gone better than expected - 668p on the bid now.

[marine boy] 19/11/2015 15:27

Santa rally. I always get my presents in early :-)

[nurdin] 19/11/2015 14:55

The chart is turning up with intent :o)

[scottishfield] 17/11/2015 15:47

Tks M Boy. invested today.

[marine boy] 17/11/2015 07:37

arc en ciel (post 705) says Clinigen was mentioned in October's SCSW but I don't subscribe & have not read the article.

[scottishfield] 16/11/2015 20:35

Was it a scsw tip recently Marine Boy?

[sonomic] 16/11/2015 20:19

nah its just practice and warming up me thinks...

[nurdin] 16/11/2015 16:54

Lovely close.Perhaps beginning of an ascent back to previous highs? Probably jinxed it now lol.

[marine boy] 13/11/2015 13:50

As long as it's a friendly monster.

[arc en ciel] 13/11/2015 12:03

Marine Boy: Don't be too hard on yourself.

Perhaps this will help lift your spirits- SCSW said in its October edition, with the share-price at 705p:

"Starting to look like a monster. Keep holding".

[marine boy] 13/11/2015 10:09

Funny how when the price goes against one, one thinks it's MM manipulation but when it goes in one's favour it's down to pure stock picking brilliance and a fantastic BOD. Wish I had waited 'till this morning at 588p but still confident of a recovery above 600p soon.

[nurdin] 13/11/2015 09:54

Had a few...looking very cheap here imo.

[marine boy] 12/11/2015 18:39

Buyers dried up it seems, except me - couldn't resist a top up at 600p.
Market appears in meltdown atm. Things will look better in the Spring. Time to set the alarm clock & hibernate.